Powered by
DETROIT–The Barbara Ann Karmanos Cancer Institute, a National Cancer Institute-Designated Comprehensive Cancer Center, has become the first cancer center to receive the SoftVue 3D Whole Breast Ultrasound Tomography System following …
ANN ARBOR–Endra Life Sciences Inc. (NASDAQ: NDRA), the Ann Arbor-based ultrasound technology developer, has won two new patents from the United States Patent and Trademark Office. They are U.S. Patent …
ANN ARBOR—HistoSonics, developer of a non-invasive sonic beam therapy, announced today the treatment of the first patient in the #HOPE4LIVER US Study. The investigational device study was approved by the …
ANN ARBOR—HistoSonics Inc. announced that it had received an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration (FDA) to begin a clinical trial of its new technology, …